全文获取类型
收费全文 | 115065篇 |
免费 | 11045篇 |
国内免费 | 7139篇 |
专业分类
耳鼻咽喉 | 953篇 |
儿科学 | 1913篇 |
妇产科学 | 1584篇 |
基础医学 | 12137篇 |
口腔科学 | 1942篇 |
临床医学 | 14625篇 |
内科学 | 16723篇 |
皮肤病学 | 1328篇 |
神经病学 | 5135篇 |
特种医学 | 4229篇 |
外国民族医学 | 60篇 |
外科学 | 11567篇 |
综合类 | 20360篇 |
现状与发展 | 21篇 |
一般理论 | 23篇 |
预防医学 | 8789篇 |
眼科学 | 2714篇 |
药学 | 13355篇 |
102篇 | |
中国医学 | 7112篇 |
肿瘤学 | 8577篇 |
出版年
2024年 | 374篇 |
2023年 | 1559篇 |
2022年 | 4125篇 |
2021年 | 5379篇 |
2020年 | 4185篇 |
2019年 | 3433篇 |
2018年 | 3709篇 |
2017年 | 3555篇 |
2016年 | 3359篇 |
2015年 | 5019篇 |
2014年 | 6334篇 |
2013年 | 6236篇 |
2012年 | 9136篇 |
2011年 | 9806篇 |
2010年 | 6835篇 |
2009年 | 5595篇 |
2008年 | 6834篇 |
2007年 | 6669篇 |
2006年 | 6192篇 |
2005年 | 5624篇 |
2004年 | 4227篇 |
2003年 | 3834篇 |
2002年 | 3294篇 |
2001年 | 2682篇 |
2000年 | 2500篇 |
1999年 | 2338篇 |
1998年 | 1288篇 |
1997年 | 1320篇 |
1996年 | 1005篇 |
1995年 | 851篇 |
1994年 | 724篇 |
1993年 | 493篇 |
1992年 | 719篇 |
1991年 | 588篇 |
1990年 | 535篇 |
1989年 | 486篇 |
1988年 | 379篇 |
1987年 | 389篇 |
1986年 | 288篇 |
1985年 | 233篇 |
1984年 | 175篇 |
1983年 | 114篇 |
1982年 | 85篇 |
1981年 | 105篇 |
1980年 | 62篇 |
1979年 | 91篇 |
1978年 | 62篇 |
1977年 | 43篇 |
1974年 | 49篇 |
1972年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
The objective of this study was to determine whether the development of tolerance to CP 55,940, a potent cannabinoid agonist, was due to changes in the receptor or second messenger system. ICR mice treated with CP 55,940 (2 mg/kg) twice a day for 6 and one-half days developed a high degree of tolerance to the pharmacological effects of CP 55,940. The ability of CP 55,940 to produce motor hypoactivity, hypothermia and immobility was reduced 163-, 97- and 19-fold, respectively. Evaluation of 3H-CP 55,940 binding to rat brain membranes indicated no difference in receptor affinity between the vehicle- and CP 55,940-treated animals. However, these binding studies revealed a 50% decrease in receptor number in the cerebellum of the CP 55,940-tolerant mice. Although cAMP is generally considered to be the second messenger for cannabinoid receptors, little difference was observed in the inhibitory effects of CP 55,940 on adenylyl cyclase activity in cerebellum between vehicle and drug-treated mice. However, there was an increase in receptor mRNA which suggests a compensation for receptor loss. There are several possible explanations for these results. There may be sufficient spare receptors such that CP 55,940-tolerant mice are capable of producing a maximal effect on the second messenger system. On the other hand, one could conclude that cannabinoid receptor down-regulation does not account for the development of tolerance to all of the effects of CP 55,940 in mice. 相似文献
132.
肺癌脑转移83例临床分析 总被引:2,自引:0,他引:2
我所内科1988 ̄1993年收治肺癌患者1006例,脑转移83例,占8.25%,由于治疗方法不同,其预后极其不同。手术切除加放疗化疗与单纯放疗化疗的生存率有显著性差异(P〈0.05),放疗化疗综合组疗效预后好于单一治疗组(P〈0.05)。因此在肺癌确诊后应常规作脑影像学检查,可早期诊断,这是提高疗效和生存捏的重要因素。 相似文献
133.
卡介苗激活杀伤细胞抗膀胱肿瘤作用研究 总被引:1,自引:0,他引:1
为了进一步探讨BCG抗膀胱肿瘤的作用机理,采取15例膀胱肿瘤患者外周血单个核细胞(PBMC),置于含BCG或IL2的培养基中培养,计算扩增倍数,检测培养细胞抗自体及异体膀胱癌细胞活性。结果:卡介苗激活杀伤细胞(BAK)与淋巴因子激活杀伤细胞(LAK)分别于培养第7和第3天达增殖高峰,对自体瘤杀伤率分别为36.2%和31.4%,差异有显著性(P<0.05);对异体瘤杀伤率分别为25.2%和28.3%,差异无显著性。结果表明:BAK细胞抗自体瘤活性高于LAK细胞,死BCG对PBMC无激活作用,BAK细胞抗肿瘤效应可能是BCG抗膀胱肿瘤重要作用机理之一。 相似文献
134.
蜂王浆冻干粉对小鼠肿瘤的抑制作用 总被引:4,自引:0,他引:4
目的研究蜂王浆冻干粉对小鼠肿瘤的抑制作用.方法按每公斤体重0g、0.25g、0.50g、0.75g设对照及低、中、高3个剂量组,经口给予蜂王浆冻干粉30d后,接种小鼠肉瘤180(S180)和艾氏癌腹水型(EAC)两个瘤种.结果在两次重复的小鼠S180和EAC抑瘤试验中发现中剂量组瘤重明显低于阴性对照组(P<0.05),抑制率可达34%;中剂量组荷瘤小鼠平均生存时间均明显高于对照组(P<0.05).结论蜂王浆冻干粉具有抑制肿瘤的作用. 相似文献
135.
136.
采用高渗盐液,抗休克裤及两者联用纠正大鼠早期失血性休克。结果显示,单独使用AST,仅见动脉血压短时间回升,而单用HTS,血压则明显回升。若先用AST,再注入HTS,也能取得明显效果。失血休克大鼠血浆纤维连接蛋白水平显著降低,各组之间均无差异血浆脂质过氧化物-丙二醛的含量明显增加,且在HTS组,HTS+AST组与NS对照组之间有显著差异。 相似文献
137.
表小檗碱对α受体的作用 总被引:2,自引:0,他引:2
表小檗碱(epiberberine,EB)是从湖北产黄连(Coptis chinensis Franch)中提取的一种生物碱,属苯喹嗪类原小檗碱,对其药理作用的研究资料甚少,未见其对α肾上腺素体作用的报道。资料表明,许多原小檗碱类化合物有α受体阻滞作用,为从该类化合物中选择 相似文献
138.
Twenty-one patients, under 6 years of age, with root avulsion of the brachial plexus were treated from 1975 to 1987. Among them, 9 had root avulsion of the upper trunk, 2 root avulsion of the lower trunk with middle trunk broken, and 10 root avulsion of the whole brachial plexus. Follow-up of 16 patients showed excellent results in 2 patients, good in 11, fair in 1 and poor in 2. It is suggested that good results can be obtained if multi-paired nerve transfer is adopted in treatment. We conclude that owing to anatomical and physiological characteristics of the respiratory system in children, it is harmful to perform phrenic nerve transfer concomitantly with intercostal nerve transfer. Advisably, two-stage operation is required, otherwise dyspnea and pneumonia are liable to occur. In addition, the time of the operation could be extended to 4-5 years after injury in children, but best results are obtained if the operation is performed within 1 year.
相似文献
139.
大鼠肝细胞Ⅰ,Ⅲ型前胶原基因表达及PDGF的影响 总被引:3,自引:1,他引:2
目的观察大鼠肝细胞Ⅰ,Ⅲ型前胶原基因的表达及PDGF对其表达的影响.方法应用原位杂交技术检测分离培养的SD大鼠肝细胞(n=30)内Ⅰ,Ⅲ型前胶原基因的表达.同时观察10μg/L(n=30)和30μg/L(n=30)PDGF促进前胶原基因表达的作用.测定基因表达颗粒总面积占细胞总面积的百分比,并作比较分析.结果无论正常肝细胞或是在两种浓度的PDGF存在时,肝细胞内均可见到Ⅰ,Ⅲ型前胶原基因的表达.正常肝细胞Ⅰ,Ⅲ型前胶原基因表达面积的百分比(%)为77±19和75±21;加10μg/LPDGF后为115±19和112±10,而加30μg/L后为152±34及181±28,且在后者中表达明显增强(P<005及P<001).结论PDGF在转录水平上促进肝细胞胶原的合成. 相似文献
140.
Haiyung Cheng Jules I. Schwartz Charles Lin Raju D. Amin James R. Seibold Kenneth C. Lasseter David L. Ebel Dominick J. Tocco J. Douglas Rogers 《Biopharmaceutics & drug disposition》1994,15(5):409-418
MK-679 (R(?)-3-((3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)(3-(dimethylamino)-3-oxopropyl)thio)methyl)thio(propanoic acid) is a potent and specific LTD4-receptor antagonist. The disposition of MK-679 was investigated in a three-way crossover study in 12 healthy males receiving single intravenous doses of 75, 250, and 500 mg of MK-679. A greater than proportional increase in the area under the plasma concentration—time curve of MK-679 was observed with increase in dose. The plasma concentration data for each subject fitted well to the differential equations for a two-compartment model with linear tissue distribution and Michaelis-Menten elimination from the central compartment, indicating that the elimination of MK-679 in humans is saturable. In a previous study, the disposition of MK-679 in humans was also dose-dependent when given together with its S(+)-isomer, L-668,018. Thus, the disposition of MK-679 in humans is dose-dependent regardless of the presence of its stereoisomer. Also, the bioavailability of MK-679 was determined in six healthy males receiving simultaneously an oral dose of 250 mg of MK-679 and intravenous infusion of 1 mg 14C-MK-679. Results of this study indicate that the oral bioavailability of MK-679 is nearly quantitative. 相似文献